Ohio Public Employees Retirement System (OPERS)
NKTR icon

Ohio Public Employees Retirement System (OPERS)’s Nektar Therapeutics NKTR Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,429
Closed -$62.8K – 2358
2025
Q2 		$62.8K Sell
2,429
-5,800
-70% -$65.1K ﹤0.01% 1872
2025
Q1 		$83.9K Sell
8,229
-1,242
-13% -$16.2K ﹤0.01% 1793
2024
Q4 		$132K Sell
9,471
-1,133
-11% -$20K ﹤0.01% 1740
2024
Q3 		$207K Sell
10,604
-67
-0.6% -$1.28K ﹤0.01% 1544
2024
Q2 		$198K Sell
10,671
-646
-6% -$13.6K ﹤0.01% 1365
2024
Q1 		$159K Sell
11,317
-7,011
-38% -$73.4K ﹤0.01% 1376
2023
Q4 		$155K Sell
18,328
-2,347
-11% -$17.8K ﹤0.01% 1404
2023
Q3 		$185K Sell
20,675
-67
-0.3% -$645 ﹤0.01% 1370
2023
Q2 		$179K Buy
20,742
+8,258
+66% +$88.1K ﹤0.01% 1396
2023
Q1 		$132K Hold
12,484
– – ﹤0.01% 1428
2022
Q4 		$423K Buy
12,484
+9,476
+315% +$459K ﹤0.01% 1306
2022
Q3 		$144K Hold
3,008
– – ﹤0.01% 1538
2022
Q2 		$171K Sell
3,008
-3,216
-52% -$203K ﹤0.01% 1519
2022
Q1 		$503K Sell
6,224
-208
-3% -$30.8K ﹤0.01% 1339
2021
Q4 		$1.3M Sell
6,432
-172
-3% -$37.3K ﹤0.01% 1208
2021
Q3 		$1.78M Sell
6,604
-149
-2% -$35.8K 0.01% 1151
2021
Q2 		$1.74M Buy
6,753
+618
+10% +$171K 0.01% 1170
2021
Q1 		$1.84M Buy
6,135
+323
+6% +$101K 0.01% 1091
2020
Q4 		$1.48M Buy
5,812
+1,137
+24% +$294K 0.01% 1090
2020
Q3 		$1.16M Buy
4,675
+208
+5% +$65.4K 0.01% 1051
2020
Q2 		$1.55M Buy
4,467
+62
+1% +$19.3K 0.01% 1012
2020
Q1 		$1.18M Buy
4,405
+596
+16% +$184K 0.01% 997
2019
Q4 		$1.23M Sell
3,809
-75
-2% -$21.7K 0.01% 1102
2019
Q3 		$1.06M Buy
3,884
+6
+0.2% +$2.2K 0.01% 1163
2019
Q2 		$2.07M Buy
3,878
+6
+0.2% +$3.01K 0.01% 956
2019
Q1 		$1.95M Buy
3,872
+7
+0.2% +$4.15K 0.01% 988
2018
Q4 		$1.91M Sell
3,865
-385
-9% -$232K 0.01% 906
2018
Q3 		$3.89M Sell
4,250
-23
-0.5% -$19.6K 0.02% 750
2018
Q2 		$3.13M Buy
+4,273
New +$4.93M 0.02% 839

Other funds holding NKTR

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s NKTR Position: Q3 2025 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Nektar Therapeutics (NKTR) in Q3 2025, closing a stake of 2,429 shares — an estimated $62.8K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in NKTR in Q2 2018 and held it in 29 quarters. The position peaked at $3.89M in Q3 2018. 154 funds tracked by Wall St. Rank hold NKTR as of Q3 2025.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Nektar Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 2,429 Nektar Therapeutics shares in Q3 2025, an estimated $62.8K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Nektar Therapeutics in Q2 2018 and held it in 29 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Nektar Therapeutics position peaked at $3.89M in Q3 2018.
  • 154 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2025.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2025, filed 14 Nov 2025.